Guru Ownership Trend
Guru Analysis for Ultragenyx Pharmaceutical Inc. (RARE)
Ultragenyx Pharmaceutical Inc. (RARE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $226.8 M.
Top institutional holders include Cliff Asness and Frank Sands.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $70.24 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 298.9%. Conversely, Jefferies Group reduced exposure by 96.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Ultragenyx Pharmaceutical Inc. (RARE)
Major holders include Cliff Asness ($95.91 M), Frank Sands ($67.34 M), Steven Cohen ($18.71 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 9.47 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $70.24 M, with 4 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited RARE. The total reported sell value was $20.82 M.
Yes, 1 managers opened new positions in RARE, and 3 increased their existing holdings. The total reported buy value was $91.06 M.
